• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Interindividual and intraindividual variability in plasma fibrinogen, TPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris.

作者信息

de Maat M P, de Bart A C, Hennis B C, Meijer P, Havelaar A C, Mulder P G, Kluft C

机构信息

Gaubius Laboratory, TNO-PG, Leiden, The Netherlands.

出版信息

Arterioscler Thromb Vasc Biol. 1996 Sep;16(9):1156-62. doi: 10.1161/01.atv.16.9.1156.

DOI:10.1161/01.atv.16.9.1156
PMID:8792769
Abstract

We compared intraindividual and interindividual variability in the plasma levels of fibrinogen, tissue-type plasminogen activator (TPA) antigen, plasminogen activator inhibitor (PAI) activity, and C-reactive protein (CRP) in 20 healthy, young individuals and 26 patients with stable angina pectoris (AP) who were at higher risk for cardiovascular disease. For each of the four parameters, the contribution of the intraindividual variation to the total variance (13% and 9% for fibrinogen, 3% and 5% for TPA antigen, 4% and 20% for In[PAI activity], and 14% and 9% for In[CRP] for the healthy volunteers and AP patients, respectively) was smaller than the contribution from the interindividual variation. These results indicate that single sampling is sufficient to assess an individual level for TPA antigen and PAI activity, whereas duplicate sampling for fibrinogen and triplicate sampling for CRP are recommended. In an epidemiological study the sample sizes, based on the variances found in the transverse part of the study, needed to detect a 15% difference between the two groups (with alpha = 0.01 and a statistical power = .90) are 31 and 40 for fibrinogen, 568 and 146 for TPA antigen, 603 and 119 for PAI activity, and 1490 and 2263 for CRP in healthy volunteers and patients with AP, respectively. Additionally, we studied the contribution of genetic polymorphisms of the B beta-fibrinogen (Bcl I and G-->A-455) and PAI activity (HindIII and CA-repeat) genes to intraindividual and interindividual variation. Fibrinogen genotypes were associated with plasma fibrinogen levels in the volunteers but not in the AP patients. No effects of fibrinogen or PAI polymorphisms on intraindividual variation were observed in either healthy individuals or AP patients. In this study intraindividual variation in plasma levels of the cardiovascular risk indicators fibrinogen, TPA antigen, PAI activity, and CRP was small when compared with the interindividual variation in healthy, young volunteers and patients with stable AP.

摘要

相似文献

1
Interindividual and intraindividual variability in plasma fibrinogen, TPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris.
Arterioscler Thromb Vasc Biol. 1996 Sep;16(9):1156-62. doi: 10.1161/01.atv.16.9.1156.
2
Increased plasminogen activator inhibitor antigen levels in diabetic patients with stable angina.稳定型心绞痛糖尿病患者纤溶酶原激活物抑制剂抗原水平升高。
Blood Coagul Fibrinolysis. 1991 Feb;2(1):41-5. doi: 10.1097/00001721-199102000-00006.
3
Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase response.心绞痛患者血浆纤溶酶原激活物抑制剂-1。血浆胰岛素和急性期反应的影响。
Arteriosclerosis. 1989 May-Jun;9(3):362-7. doi: 10.1161/01.atv.9.3.362.
4
Modulation of plasma fibrinogen levels by ticlopidine in healthy volunteers and patients with stable angina pectoris.噻氯匹定对健康志愿者和稳定型心绞痛患者血浆纤维蛋白原水平的调节作用。
Thromb Haemost. 1996 Aug;76(2):166-70.
5
Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.在男性中,无论年龄、肥胖、体脂分布及相关代谢参数如何,雄激素活性较低都与促血栓形成因子的血浆水平较高相关。
Metabolism. 1997 Nov;46(11):1287-93. doi: 10.1016/s0026-0495(97)90232-8.
6
Inheritance conjointly contributing to fibrinolysis and hyperlipidemia.共同导致纤维蛋白溶解和高脂血症的遗传因素。
Metabolism. 1993 Nov;42(11):1410-9. doi: 10.1016/0026-0495(93)90191-p.
7
Testosterone does not adversely affect fibrinogen or tissue plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1) levels in 46 men with chronic stable angina.睾酮对46名慢性稳定型心绞痛男性患者的纤维蛋白原、组织型纤溶酶原激活物(tPA)及纤溶酶原激活物抑制剂-1(PAI-1)水平无不良影响。
Eur J Endocrinol. 2005 Feb;152(2):285-91. doi: 10.1530/eje.1.01848.
8
Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.止血因素与心绞痛患者心肌梗死或猝死风险。欧洲血栓形成与残疾协同行动心绞痛研究组
N Engl J Med. 1995 Mar 9;332(10):635-41. doi: 10.1056/NEJM199503093321003.
9
Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.2型糖尿病患者后代纤溶酶原激活物抑制剂-1活性增加:与血浆胰岛素水平无关。
Diabetes Care. 2000 Jan;23(1):88-92. doi: 10.2337/diacare.23.1.88.
10
Circulating levels of plasminogen activator inhibitor type-1, tissue plasminogen activator, and thrombomodulin in hemodialysis patients: biochemical correlations and role as independent predictors of coronary artery stenosis.血液透析患者中纤溶酶原激活物抑制剂-1、组织纤溶酶原激活物和血栓调节蛋白的循环水平:生化相关性及作为冠状动脉狭窄独立预测指标的作用
J Am Soc Nephrol. 2001 Jun;12(6):1255-1263. doi: 10.1681/ASN.V1261255.

引用本文的文献

1
Time variability of C-reactive protein: implications for clinical risk stratification.C 反应蛋白的时间变异性:对临床风险分层的影响。
PLoS One. 2013 Apr 8;8(4):e60759. doi: 10.1371/journal.pone.0060759. Print 2013.
2
Within-person variability in high-sensitivity C-reactive protein.高敏C反应蛋白的个体内变异性。
Arch Intern Med. 2012 Oct 22;172(19):1519-21. doi: 10.1001/archinternmed.2012.3712.
3
Reliability of serum biomarkers of inflammation from repeated measures in healthy individuals.健康个体中重复测量的血清炎症生物标志物的可靠性。
Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1167-70. doi: 10.1158/1055-9965.EPI-12-0110. Epub 2012 May 7.
4
Socioeconomic position and inflammatory and immune biomarkers of cardiovascular disease: applications to the Panel Study of Income Dynamics.社会经济地位与心血管疾病的炎症和免疫生物标志物:在收入动态面板研究中的应用
Biodemography Soc Biol. 2009;55(2):178-205. doi: 10.1080/19485560903382304.
5
Intra-individual variation in serum C-reactive protein over 4 years: an implication for epidemiologic studies.血清 C-反应蛋白在 4 年内的个体内变化:对流行病学研究的启示。
Cancer Causes Control. 2010 Jun;21(6):847-51. doi: 10.1007/s10552-010-9511-z. Epub 2010 Feb 5.
6
Discordances among different tools used to estimate cardiovascular risk in postmenopausal women.不同工具用于评估绝经后女性心血管风险时的差异。
Can J Cardiol. 2009 Dec;25(12):e413-6. doi: 10.1016/s0828-282x(09)70535-5.
7
Long-term C-reactive protein variability and prediction of metabolic risk.长期C反应蛋白变异性与代谢风险预测
Am J Med. 2009 Jan;122(1):53-61. doi: 10.1016/j.amjmed.2008.08.023.
8
Precision of biomarkers to define chronic inflammation in CKD.用于定义慢性肾脏病中慢性炎症的生物标志物的精准度。
Am J Nephrol. 2008;28(5):808-12. doi: 10.1159/000135692. Epub 2008 May 28.
9
C-reactive protein increases plasminogen activator inhibitor-1 expression in human endothelial cells.C反应蛋白增加人内皮细胞中纤溶酶原激活物抑制剂-1的表达。
Thromb Res. 2008;122(1):125-33. doi: 10.1016/j.thromres.2007.09.006. Epub 2007 Oct 22.
10
Serum carotenoids and vitamins in relation to markers of endothelial function and inflammation.血清类胡萝卜素和维生素与内皮功能及炎症标志物的关系
Eur J Epidemiol. 2004;19(10):915-21. doi: 10.1007/s10654-004-5760-z.